Studies of Polymorphism of Amyloid-β42 Peptide from Different Suppliers

Journal of Alzheimer's Disease

Volumn 47, Issue 3, 2015, Pages 583-593

  Suvorina, Mariya Yu ^a   Selivanova, Olga M ^a   Grigorashvili, Elizaveta I ^a   Nikulin, Alexey D ^a   Marchenkov, Victor V ^a   Surin, Alexey K ^a,b   Galzitskaya, Oxana V ^a  

^a INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

^b STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

Author keywords

Alzheimer's disease; amyloid fibril; A 42 peptide; electron microscopy; mass spectroscopy; oligomer; prion like behavior; protofibril

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-42]; PROTEIN AGGREGATE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PRION; RECOMBINANT PROTEIN;

ARTICLE; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; FLUORESCENCE SPECTROSCOPY; HUMAN; MASS SPECTROMETRY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; X RAY DIFFRACTION; CHEMISTRY; COMPARATIVE STUDY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PH; PRION; PROTEIN MULTIMERIZATION; QUALITY CONTROL; SPECTROFLUOROMETRY; STANDARDS;

AMYLOID BETA-PEPTIDES; HUMANS; HYDROGEN-ION CONCENTRATION; MASS SPECTROMETRY; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; PRIONS; PROTEIN MULTIMERIZATION; QUALITY CONTROL; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; X-RAY DIFFRACTION;

EID: 84938699749     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150147     Document Type: Article

References (35)

1. Mattson MP (2001) Cellular and molecular mechanisms underlying synaptic degeneration and neuronal death in Alzheimers disease. In Pathogenesis of Neurodegenerative Disorders, Mattson MP, ed. Humana Press, Totowa, NJ, pp. 113-138.
2. Sunde M, Blake C (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50, 123-159.
3. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimers disease: A review of progress. J Neurol Neurosurg Psychiatry 66, 137-147.
4. Glenner GG, Wong CW (1984) Alzheimers disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890.
5. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimers disease. Trends Pharmacol Sci 12, 383-388.
6. Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol Zurich Switz 1, 279-286.
7. Chun W, Johnson GVW (2007) The role of tau phosphorylation and cleavage in neuronal cell death. Front Biosci J Virtual Libr 12, 733-756.
8. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, Schubert D, Riek R (2005) 3D structure of Alzheimers amyloid-beta (1-42) fibrils. Proc Natl Acad Sci U S A 102, 17342-17347.
9. Jeong JS, Ansaloni A, Mezzenga R, Lashuel HA, Dietler G (2013) Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation. J Mol Biol 425, 1765-1781.
10. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimers disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
11. Selkoe DJ (2004) Cell biology of protein misfolding: The examples of Alzheimers and Parkinsons diseases. Nat Cell Biol 6, 1054-1061.
12. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloidbeta peptides differentially affect neuronal viability. J Biol Chem 277, 32046-32053.
13. Garzon-Rodriguez W, Sepulveda-Becerra M, Milton S, Glabe CG (1997) Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations. J Biol Chem 272, 21037-21044.
14. Harper JD, Wong SS, Lieber CM, Lansbury PT (1999) Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in Alzheimers disease. Biochemistry (Mosc) 38, 8972-8980.
15. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
16. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37, 925-937.
17. Jarrett JT, Lansbury PT (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimers disease and scrapie? Cell 73, 1055-1058.
18. Carrotta R, Manno M, Bulone D, Martorana V, San Biagio PL (2005) Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem 280, 30001-30008.
19. Talmard C, Leuma Yona R, Faller P (2009) Mechanism of zinc (II) -promoted amyloid formation: zinc (II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein (1-28) . J Biol Inorg Chem 14, 449-455.
20. Ma Q-F, Hu J, Wu W-H, Liu H-D, Du J-T, Fu Y, Wu Y-W, Lei P, Zhao Y-F, Li Y-M (2006) Characterization of copper binding to the peptide amyloid-beta (1-16) associated with Alzheimers disease. Biopolymers 83, 20-31.
21. Turner AJ, Fisk L, Nalivaeva NN (2004) Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann N Y Acad Sci 1035, 1-20.
22. Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA (2012) Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res 40, e107.
23. Kozin SA, Cheglakov IB, Ovsepyan AA, Telegin GB, Tsvetkov PO, Lisitsa AV, Makarov AA (2013) Peripherally applied synthetic peptide isoAsp7-Aβ (1-42) triggers cerebral β-Amyloidosis. Neurotox Res 24, 370-376.
24. Hartl FU, Hayer-Hartl M (2009) Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol 16, 574-581.
25. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899.
26. Dovidchenko NV, Finkelstein AV, Galzitskaya OV (2014) How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. I. Modeling the amyloid protofibril formation. J Phys Chem B 118, 1189-1197.
27. Selivanova OM, Suvorina MY, Dovidchenko NV, Eliseeva IA, Surin AK, Finkelstein AV, Schmatchenko VV, Galzitskaya OV (2014) How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. II. Experimental application for insulin and LysPro insulin: Aggregation morphology, kinetics, and sizes of nuclei. J Phys Chem B 118, 1198-1206.
28. Qiang W, Kelley K, Tycko R (2013) Polymorph-specific kinetics and thermodynamics ofβ-Amyloid fibril growth.JAm Chem Soc 135, 6860-6871.
29. Petkova AT, Leapman RD, Guo Z, Yau W-M, Mattson MP, Tycko R (2005) Self-propagating, molecular-level polymorphism in Alzheimers beta-Amyloid fibrils. Science 307, 262-265.
30. Stöhr J, Condello C, Watts JC, Bloch L, Oehler A, Nick M, DeArmond SJ, Giles K, DeGrado WF, Prusiner SB (2014) Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice. Proc Natl Acad Sci U S A 111, 10329-10334.
31. Cohen SIA, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TPJ (2013) Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A 110, 9758-9763.
32. Nielsen EH, Nybo M, Svehag SE (1999) Electron microscopy of prefibrillar structures and amyloid fibrils. Methods Enzymol 309, 491-496.
33. Butterfield DA, Sultana R (2011) Methionine-35 of aβ (1-42) : Importance for oxidative stress in Alzheimer disease. J Amino Acids 2011, 198430.
34. Fändrich M, Meinhardt J, Grigorieff N (2009) Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion 3, 89-93.
35. Lu J-X, Qiang W, Yau W-M, Schwieters CD, Meredith SC, Tycko R (2013) Molecular structure of β-Amyloid fibrils in Alzheimers disease brain tissue. Cell 154, 1257-1268.